OR11-6 Long-term mortality in patients with isolated GHD, ISS, and SGA treated with recombinant GH during childhood in Sweden: Application of a mortality model developed from the general population

K. Albertsson Wikland, L. Sävendahl, A. Märtensson, B. Borgström, A. Niklasson, N.G. Pehrson, P. Bang, J. Dahlgren, J. Gustafson, L. Hagenäs, B. Kriström, S. Norgren, A. Odén
  • Growth Hormone & IGF Research, October 2012, Elsevier
  • DOI: 10.1016/s1096-6374(12)60081-1
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Lars Sävendahl